On Dec. 24, 2024, the Minnesota Department of Natural Resources (MNDNR) is investigating a number of wild waterfowl…
On Dec. 19, 2024, researchers from The Hospital for Sick Children (SickKids) in Canada and the Istituto Giannina…
On Dec. 18, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported that a patient has…
On Dec. 12, 2024, a study co-lead by researchers from the University of British Columbia, Vancouver General Hospital…
On Dec. 11, 2024 the Board of Directors of AquaBounty Technologies announced that the Company was winding down…
On Dec. 10, 2024, the Pan American Health Organization (PAHO) reported on three transmissible diseases affecting the Region…
On Nov. 22, 2024, the Public Health Agency of Canada (PHAC) confirmed the first case of clade I…
On Nov. 6, 2024, the World Health Organization announced that the Access and Allocation Mechanism (AAM) for mpox…
On Oct. 31, 2024, researchers from the University of Pittsburgh reported results of a study that showed drug-related…
On Oct. 8, 2024, Okanagan Specialty Fruits® (OSF), the developer and grower behind the innovative Arctic® apple varieties, announced that its…
On Jul. 23, 2024, a study published in Cell Reports revealed that seabirds likely facilitated the spread of…
On May 31, 2024, a national research coalition led by the University of British Columbia (UBC) announced a…
On May 2, 2024, scientists at the U.S. Department of Agriculture (USDA)ï¾’s Agricultural Research Service (ARS) and university…
On Mar. 4, 2024, Hugel America announced it received U.S. Food and Drug Administration (FDA) approval on its…
On Jan. 15, 2024, CSL announced that Swissmedic had authorised HEMGENIX® (etranacogene dezaparvovec), the first and currently only gene…
On Jan. 5, 2024, the U.S. Food and Drug Administration (FDA) authorized Florida’s Agency for Health Care Administration’s…
On Dec. 5, 2023, Novavax announced that Health Canada had granted expanded authorization for Nuvaxovid XBB.1.5 Vaccine (Recombinant…
On Sept. 28, 2023, Pfizer and BioNTech that Health Canada had authorized the companies’ Omicron XBB.1.5-adapted monovalent COVID-19…
On Jun. 22, 2023 AquaBounty Technologies announced that the Company will pause the construction of its farm in…
On Mar. 17, 2023, PrairiesCan announced $80,514,000 over five years to support the Canadian Critical Drug Initiativeï¾—an integrated…
On Feb. 17, 2023, Moderna announced that Health Canada had authorized the use of its Omicron-targeting bivalent COVID-19…
On Feb. 14, 2023, the Pacific Economic Development Agency of Canada (PacifiCan), announced $14.5 million in funding for…
On Dec. 7, 2022, Novavax announced that Health Canada had approved a supplement to a New Drug Submission…
On Nov. 18, 2022, Novavax announced that Health Canada had granted expanded authorization for Nuvaxovid (COVID-19 Vaccine (Recombinant…
On Nov. 4, 2022, Moderna announced that Health Canada had authorized the use of its BA.4/BA.5 Omicron-targeting bivalent…
On Oct. 7, 2022, Pfizer and BioNTech announced that Health Canada had authorized COMIRNATY Original & Omicron BA.4/BA.5…
On Sept. 27, 2022, the National Institutes of Health (NIH) announced that a large international study had confirmed…
On Sept. 7, 2022, the U.S. Food and Drug Administration (FDA) announced it had approved Revance Therapeutics’ DAXXIFY…
On Aug. 23, 2022, Moderna announced that the Government of Canada had exercised its option to purchase an…
On Jul. 14, 2022, Moderna announced that Health Canada had approved the use of Moderna’s mRNA COVID-19 vaccine,…